List view / Grid view
21 September 2015 | By SomaLogic
The SOMAscan™ assay is a highly multiplexed, sensitive, quantitative and reproducible proteomic tool for discovering biomarkers for drug discovery...
21 September 2015 | By BioTek
The Synergy Neo2 Multi-Mode Reader is designed to provide high temporal resolution in drug target kinetics applications...
In much the same way that kinases and phosphatases attach and remove phosphate groups from proteins to modulate their activity, there are a series of enzymes (E1, E2, E3) that add one or more ubiquitins onto a protein, as well as enzymes that remove them (deubiquitinases; DUBs), thereby regulating their…
17 September 2015 | By Victoria White
The researchers also determined that the level of biomarkers associated with ovarian cancer does not simply increase or decrease over the course of the disease...
17 September 2015 | By Victoria White
The research collaboration brings together Amgen's capabilities in target discovery and protein therapeutics with Xencor's XmAb bispecific technology platform...
16 September 2015 | By Victoria White
A team at the International Centre for Genetic Engineering and Biotechnology (ICGEB) will join forces with MRC Technology to take on the project...
15 September 2015 | By
Since initiating the project in 2014, significant progress has been made towards the invention of new compounds with activity against both gram-positive and gram-negative bacteria...
14 September 2015 | By IntelliCyt
Immunology Screening on the iQue Screener: Assays for Immune-Modulators and Immunotherapy...
14 September 2015 | By Victoria White
The five-year programme will focus on the development of ‘nanomedicine’ in the treatment of pancreatic cancer, for which current treatment options are limited...
14 September 2015 | By Victoria White
The new laboratory, opened in Cambridge, will focus on the discovery and development of novel biologic cancer treatments and diagnostics...
14 September 2015 | By Victoria White
The potential new antibiotics are unlike contemporary antibiotics because they contain iridium, a silvery-white transition metal...
14 September 2015 | By Victoria White
WIPO Re:Search provides access to the intellectual property of certain pharmaceutical compounds, technologies, know-how and data for R&D activities around TB and malaria...
11 September 2015 | By Victoria White
Researchers have developed a new method for studying the targets and effects of cancer drugs using data from discovery mass spectrometry experiments...
11 September 2015 | By Victoria White
The new technique could cut the potential for side effects and help usher kinase inhibitors past strict regulatory hurdles...
11 September 2015 | By Victoria White
Gencia and Takeda aim to jointly research and develop two preclinical drug candidates, one each in the areas of inflammation and oncology...
